Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Takako Ishibashi"'
Autor:
Masaaki Kondo, Manabu Morimoto, Satoshi Kobayashi, Shinichi Ohkawa, Hisashi Hidaka, Takahide Nakazawa, Hiroshi Aikata, Takeshi Hatanaka, Daichi Takizawa, Kotaro Matsunaga, Chiaki Okuse, Michihiro Suzuki, Masataka Taguri, Takako Ishibashi, Kazushi Numata, Shin Maeda, Katsuaki Tanaka
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background The efficacy of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) remains unclear. We conducted a multi-center randomized phase II study comparing a sequential HAIC-sorafenib regimen versus
Externí odkaz:
https://doaj.org/article/d171f0802f7e4830bd1e315ef0ce26b0
Autor:
Keisho Chin, Haruhiko Cho, Hideaki Bando, Kohei Shitara, Yoshiaki Nakamura, Kazuhiro Yoshida, Eiji Oki, Takeharu Yamanaka, Motohiro Hirao, Kazunari Misawa, Mitsuru Sasako, Masanori Terashima, Takako Ishibashi, Tetsu Fukunaga, Yoshiyuki Kawashima, Masahiro Gotoh, Yasunori Emi, Hitoshi Katai
Publikováno v:
Annals of Surgical Oncology. 26:465-472
Two phase 2 trials of oxaliplatin-containing adjuvant therapy for patients with gastric cancer (GC) after D2 gastrectomy were conducted in Japan. The SOXaGC trial evaluated the tolerability and safety of adjuvant therapy with S-1 plus oxaliplatin (SO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::478b4893d94718a45a6c7c397ca95a75
https://doi.org/10.1245/s10434-018-7063-8
https://doi.org/10.1245/s10434-018-7063-8
Autor:
Masataka Taguri, Michihiro Suzuki, Katsuaki Tanaka, Hisashi Hidaka, Takeshi Hatanaka, Masaaki Kondo, Daichi Takizawa, Kazushi Numata, Takahide Nakazawa, Chiaki Okuse, Shinichi Ohkawa, Shin Maeda, Kotaro Matsunaga, Takako Ishibashi, Manabu Morimoto, Satoshi Kobayashi, Hiroshi Aikata
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background The efficacy of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) remains unclear. We conducted a multi-center randomized phase II study comparing a sequential HAIC-sorafenib regimen versus sorafenib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1ce7acb1f0719127a04f0384b81484
http://europepmc.org/articles/PMC6794885
http://europepmc.org/articles/PMC6794885
Autor:
Satoshi Kobayashi, Kuniya Tanaka, Takahide Nakazawa, Chiaki Okuse, D. Takizawa, Shin Maeda, Hisashi Hidaka, Masaaki Kondo, T. Hatanaka, Michihiro Suzuki, Kazushi Numata, Kotaro Matsunaga, Takako Ishibashi, Hiroshi Aikata, Masataka Taguri, Manabu Morimoto
Publikováno v:
Annals of Oncology. 31:S219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68adf5d8b1e8c33190689e8ec1a40332
https://doi.org/10.1016/j.annonc.2020.04.021
https://doi.org/10.1016/j.annonc.2020.04.021
Autor:
Motohiro Hirao, Mitsuru Sasako, Hideaki Bando, Takeharu Yamanaka, Eiji Oki, Masanori Terashima, Keisho Chin, Haruhiko Cho, Takako Ishibashi, Seiji Ito, Hitoshi Katai, Kazuhiro Yoshida, Tetsu Fukunaga, Yasunori Emi, Yoshiyuki Kawashima, Kohei Shitara, Masahiro Gotoh, Yoshiaki Nakamura
Publikováno v:
Journal of Clinical Oncology. 36:94-94
94 Background: Two phase II trials of oxaliplatin-based adjuvant chemotherapy for patients (pts) with gastric cancer (GC) after D2 gastrectomy have been conducted in Japan; the J-CLASSIC study of capecitabine plus oxaliplatin (CAPOX) and the SOXaGC s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ec84ed26167e5a1488c8d233861134a
https://doi.org/10.1200/jco.2018.36.4_suppl.94
https://doi.org/10.1200/jco.2018.36.4_suppl.94